2027 ICD-10-CM Diagnosis Code C65.1Malignant neoplasm of right renal pelvis
ICD-10-CM Codes›C00–D49›C64-C68›C65
- Billable — Valid for Submission
- CC — Complication or Comorbidity
- Risk Adjusts — HCC 22
- Chronic Condition
C65.1 is a billable ICD-10-CM diagnosis code for malignant neoplasm of right renal pelvis. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 656 through 658, 686 through 688. As a secondary diagnosis, it counts as a complication or comorbidity (CC) and moves an inpatient stay to a higher severity level within its MS-DRG family. It does not count, however, when the principal diagnosis is one of 27 closely related codes. Coders also document this condition as primary malignant neoplasm of renal pelvis. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Urinary system cancers - ureter and renal pelvis.
For Medicare Advantage risk adjustment, C65.1 maps to CMS-HCC Category 22 (Bladder, Colorectal, and Other Cancers) under the V28 model, adding a risk factor of about 0.363 for a community, non-dual, aged beneficiary in payment year 2027.
Code Identity
Code Classification
Medicare Risk Adjustment (HCC)Billing
C65.1 maps to a payment category in the CMS-HCC model used to risk-adjust Medicare Advantage payments. Weights are the published community factors for payment year 2027.
Source: CMS Payment Year 2027 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Primary malignant neoplasm of renal pelvis
- Primary malignant neoplasm of right kidney
- Primary malignant neoplasm of right renal pelvis
- Primary transitional cell carcinoma of kidney
- Primary transitional cell carcinoma of right kidney
- Primary transitional cell carcinoma of right renal pelvis
- Primary transitional cell carcinoma of upper urinary tract
- Transitional cell carcinoma of right kidney
- Transitional cell carcinoma of right renal pelvis
Instructional NotesGuidance
Instructions from the official ICD-10-CM Tabular List that apply to C65.1: its own notes plus those printed at C65 and Chapter 2. A note printed at a category, block or chapter applies to every code under it.
Includes
Further defines, or gives examples of, the content of the category.
- malignant neoplasm of pelviureteric junction
- malignant neoplasm of renal calyces
Notes
General instructions on how these codes are used.
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
Source: CMS ICD-10-CM Tabular List. How to read instructional notes.
Referenced in Other NotesGuidance
Instructional notes printed at other codes that name C65.1, its category, or a range that includes it.
Applicable To 2
These notes mention C65.1.
Excludes1 2
These codes carry an Excludes1 note naming C65.1: they are not reported together with it, unless the two conditions are unrelated.
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Malignant Renal Pelvis Neoplasm
a primary or metastatic malignant neoplasm that affects the renal pelvis.
Patient EducationClinical
Kidney Cancer
You have two kidneys. They are fist-sized organs on either side of your backbone above your waist. The tubes inside filter and clean your blood, taking out waste products and making urine. Kidney cancer forms in the lining of tiny tubes inside your kidneys.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert C65.1 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About C65.1Overview
What is the ICD-10 code for malignant neoplasm of right renal pelvis?
The ICD-10-CM code for malignant neoplasm of right renal pelvis is C65.1 (sometimes written as C651). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
Is C65.1 (Malignant neoplasm of renal pelvis) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report malignant neoplasm of right renal pelvis on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
What MS-DRG does C65.1 group to?
When malignant neoplasm of right renal pelvis is the principal diagnosis on an inpatient stay, it groups to MS-DRG 656, 687, 658, 657, 686, 688, with relative weights from 0.7332 to 3.2782 depending on complications. Higher weights mean higher Medicare reimbursement.
Is C65.1 a CC or MCC?
CMS lists C65.1 as a CC (complication or comorbidity) for FY 2027. Reported as a secondary diagnosis, it moves the inpatient stay to a higher-weighted DRG within its severity family. It does not count when the principal diagnosis is one of the 27 closely related codes in its exclusion list.
What is the ICD-9 equivalent of C65.1?
Under the General Equivalence Mappings, malignant neoplasm of right renal pelvis converts to ICD-9-CM 189.1 (malig neo renal pelvis). The mapping is approximate, so confirm the match fits the documentation.
What HCC is C65.1?
C65.1 (malignant neoplasm of right renal pelvis) maps to CMS-HCC Category 22 (Bladder, Colorectal, and Other Cancers), commonly written as HCC 22, in the CMS-HCC V28 model used for Medicare Advantage risk adjustment in payment year 2027. It mapped to HCC 11 under the retired V24 model. It also maps in the PACE (CMS-HCC V22), ESRD (V21), and ESRD (V24) models. In the Part D prescription drug model it maps to RxHCC 20.
Does C65.1 risk-adjust for Medicare Advantage payment?
Yes. When documented and reported on a Medicare Advantage encounter, C65.1 adds a risk adjustment factor of about 0.363 to the beneficiary's RAF score for a community, non-dual, aged enrollee (published V28 weights range from 0.314 to 0.410 depending on the payment segment). A more severe related category (HCC 17, HCC 18, HCC 19, HCC 20, and HCC 21) supersedes it when both are reported. See the full factor table on the HCC 22 category page.
